Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Antistax in Chronic Venous Insufficiency
NCT02184234Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2001
- Primary completion
- Oct 2001
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Red vine leaf extract in chronic venous insufficiency (CVI), sponsored by Boehringer Ingelheim. Started Jun 2001; status: completed.
02
Drugs
Red vine leaf extract
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT02184234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184234.